News

A Boston-based biopharmaceutical company is revolutionizing the weight-loss drug industry. Syntis Bio has created a daily ...
Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...
Protein bars offer a convenient way to top up essential nutrients when on the move, but they could also help super-boost ...
A cancer survivor who shed over 11 stone has told how she is in desperate need of surgery to remove excess skin that is ruining her life.
"There is a fashion of becoming thin and thinner. I understand there is a demand for that because I work on screen. The ...
New research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in ...
Annual Congress, CureGene Pharmaceuticals ("CureGene") announced late-breaking preclinical results for its investigational liver-targeted thyroid hormone receptor beta (THR-β) prodrug, CG-0416.
Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...
Weightwatchers and bariatric surgery had limited effects on the obese brain, but GLP-1s like Ozempic may mean new hope in ...
The popularity of weight loss drugs has caused a shortage in recent years, but how effective are they at helping with food ...
Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...